Suppr超能文献

ADP和葡萄糖作为刺激肝糖原合酶激活过程中可能的协同伙伴。

ADP and glucose as possible synergistic partners in the stimulation of liver glycogen synthase activation.

作者信息

Gilboe D P

机构信息

Veterans Administration Medical Center, Minneapolis, Minnesota 55417.

出版信息

Arch Biochem Biophys. 1990 Jan;276(1):109-15. doi: 10.1016/0003-9861(90)90016-r.

Abstract

Glucose administered either intravenously or orally causes liver glycogen synthase activation independent of a rise in circulating insulin. In vitro, physiological concentrations of glucose stimulate synthase phosphatase activity but only in the presence of a second effector which reduced the A0.5 for glucose. Caffeine and certain methylxanthines have been in vitro models for a putative natural effector. The present study demonstrates that, in vitro, ADP also reduced the A0.5 for glucose comparable to the effect of caffeine. The maximum stimulation by glucose in the presence of caffeine or ADP was comparable. The effect of ADP was specific among the major nucleoside diphosphates. However, the A0.5 for ADP was greater than the normal liver concentration which does not change in response to either glucose or insulin administration. The effect of ADP appeared distinct from that of the methylxanthines since it was observed that at near saturating concentrations of ADP and of glucose, stimulation was increased by addition of theophylline. Similarly, addition of adenosine, a natural cell constituent, caused increased stimulation. Subsequently, it was shown that adenosine reduced the A0.5 for ADP to a nearly physiological concentration. Thus, while ADP is not the inducible putative effector which has been predicted it may be part of an intracellular amplification system for glycogen synthase activation which increases the sensitivity to an induced effector. The present work suggests that the effective concentration of the natural ligand may be less than originally anticipated. This work also suggests that the putative effector could be structurally related to adenosine. Phosphorylase phosphatase activity known to be stimulated by ADP and glucose is further stimulated by the combination which may be acting in synergy.

摘要

静脉注射或口服葡萄糖会导致肝糖原合酶激活,这与循环胰岛素水平的升高无关。在体外,生理浓度的葡萄糖会刺激合酶磷酸酶活性,但仅在存在第二种效应物的情况下才会如此,该效应物会降低葡萄糖的半最大激活浓度(A0.5)。咖啡因和某些甲基黄嘌呤一直是一种假定天然效应物的体外模型。本研究表明,在体外,ADP也能降低葡萄糖的A0.5,其效果与咖啡因相当。在存在咖啡因或ADP的情况下,葡萄糖的最大刺激作用相当。在主要的核苷二磷酸中,ADP的作用具有特异性。然而,ADP的A0.5大于正常肝脏浓度,且该浓度不会因葡萄糖或胰岛素的给药而改变。ADP的作用似乎与甲基黄嘌呤不同,因为据观察,在接近饱和浓度的ADP和葡萄糖条件下,添加茶碱会增加刺激作用。同样,添加天然细胞成分腺苷也会导致刺激作用增强。随后发现,腺苷将ADP的A0.5降低到接近生理浓度。因此,虽然ADP不是预测中的可诱导假定效应物,但它可能是糖原合酶激活的细胞内放大系统的一部分,该系统会增加对诱导效应物的敏感性。目前的研究表明,天然配体的有效浓度可能比最初预期的要低。这项研究还表明,假定效应物在结构上可能与腺苷相关。已知由ADP和葡萄糖刺激的磷酸化酶磷酸酶活性会因二者的联合作用而进一步受到刺激,这种联合作用可能具有协同效应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验